TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis.

Consequently, we observed a highly significant enrichment of TROP2‐expressing cases in higher UICC stages ( p < 0.001, Figure 2 and supplementary material, Table S2 ).

also in 132,142 other papers